Lower Sfrp5 serum concentrations were associated with a higher likelihood for obesity and obesity comorbidities, such as elevated blood pressure, carotid intima media thickness, dyslipidemia and inflammation. The gene discussed is SFRP5; the disease is obesity disorder.